Video Shorts

Early RAS Inhibitor Data Signal Rare Momentum in Metastatic Pancreatic Cancer

Spotlighting the Nuances of the SERENA-6 Trial Design Following the FDA's ODAC Vote

Navigating JAK Inhibitors and Transplant in Myelofibrosis

OncLive News Roundup for the Week of 4/26

Highlighting Reconstructive Surgery Options in Breast Cancer

Breast Cancer Experts Discuss Emerging Data and Desicions

Examining the Potential Clinical Impact of the STRIKE Trial in RCC

GLP-1 Agonists Could Help Address Rising Rates of Early-Onset CRC

A New Era for RAS Inhibition in PDAC: From an “Undruggable” Target to a Potential Paradigm-Shifter

Breaking Down the Use of FES-PET/CT in Breast Cancer

The Push for Individualized Risk-Stratification Strategies in Myeloma

Is Surgery Still the Cornerstone of Curative Treatment in Esophageal Cancer?

Spotlighting Evolutions in HER2+ Breast Cancer Management

Examining the Treatment Landscape of Muscle-Invasive Bladder Cancer

OncLive News Roundup for the Week of 4/19

Discussing the Rationale for Evaluating a ROR2-Targeting ADC in OPSCC

Highlighting the Importance of Testicular Cancer Awareness

Could GLP-1 Receptor Agonists Help Reduce CRC Risk Beyond Weight Loss?

Navigating Long-Term Care Following CAR T-Cell Therapy in Myeloma

How Community Helps Oncology Professionals Achieve Work-Life Harmony

Darlifarnib in Clear Cell Renal Cell Carcinoma

Why Palliative Care Needs to Start Earlier for AYA Patients With Sarcoma

Treatment Considerations Following Covalent BTK Inhibitors in CLL

Highlighting the NCCN Advocacy Academy Program

Selecting Second-Line Therapy in R/R Myeloma

Staging Pitfalls in Esophageal Cancer Could Alter Curative Intent Decisions

The Potential Role of Tumor-Informed ctDNA Testing in Early TNBC

Should We Prescribe Exercise Like We Prescribe Chemotherapy in Sarcoma?

OncLive News Roundup for the Week of 4/12

How Should Bone Pain Be Interpreted in Patients With Cancer on Bone-Modifying Agents?